NCT00660712
Completed
Not Applicable
Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
ConditionsBipolar Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bipolar Disorder
- Sponsor
- AstraZeneca
- Enrollment
- 1018
- Locations
- 1
- Primary Endpoint
- Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients previously or currently diagnosed with bipolar disorder
- •Patients (or any of their relatives) who give a written informed consent.
Exclusion Criteria
- •Patients who were previously included in this study.
Outcomes
Primary Outcomes
Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
Secondary Outcomes
- Identification of treatment modalities selected according to the disease phase
- Identification of the number of first degree relatives diagnosed with bipolar disorder
- Evaluation of the relationship between patient and disease characteristics
- Evaluation of co-morbid psychiatric diseases
- Evaluation of the time period that elapsed since the diagnosis of bipolar disorder
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Clinical Pulmonary EmbolismAcute Pulmonary EmbolismNCT05469724Assiut University100
Recruiting
Not Applicable
Venetoclax RegistryAcute Myeloid LeukemiaNCT03662724Hannover Medical School100
Withdrawn
Not Applicable
Characteristics of Patients With COVID-19 in Meta State, ColombiaCOVIDSARS-CoV 2SARS PneumoniaSARS (Disease)SARS (Severe Acute Respiratory Syndrome)NCT04456426Hospital Departamental de Villavicencio
Completed
Not Applicable
Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination TherapyBreast CancerNCT04394247Pfizer242
Completed
Not Applicable
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on PanobinostatMultiple MyelomaNCT04150289pharmaand GmbH248